image
Healthcare - Biotechnology - NASDAQ - US
$ 7.12
1.28 %
$ 270 M
Market Cap
12.28
P/E
Price Target Average
185.58%
Revenue Forecast Estimate
20.18%
EBIT Estimate
56.40%
Net Income Estimate
--41.17%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Entrada Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for TRDA of $20.3 , with forecasts ranging from a low of $18 to a high of $23 .
TRDA Lowest Price Target Wall Street Target
18 USD 152.81%
TRDA Average Price Target Wall Street Target
20.3 USD 185.58%
TRDA Highest Price Target Wall Street Target
23 USD 223.03%
Price
Max Price Target
Min Price Target
Average Price Target
242422222020181816161414121210108866Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart TRDA

image
$450.0m$450.0m$400.0m$400.0m$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart TRDA

image
$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart TRDA

image
$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)20232023202420242025202520262026202720272028202820292029